NAYA Biosciences Cash on Hand 2010-2024 | IVF

NAYA Biosciences cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
NAYA Biosciences Annual Cash on Hand
(Millions of US $)
2024 $1
2023 $0
2022 $0
2021 $6
2020 $10
2019 $1
2018 $0
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
2011 $0
2010 $0
2009 $0
NAYA Biosciences Quarterly Cash on Hand
(Millions of US $)
2024-12-31 $1
2024-09-30 $0
2024-06-30 $1
2024-03-31 $0
2023-12-31 $0
2023-09-30 $1
2023-06-30 $0
2023-03-31 $2
2022-12-31 $0
2022-09-30 $0
2022-06-30 $2
2022-03-31 $4
2021-12-31 $6
2021-09-30 $5
2021-06-30 $7
2021-03-31 $8
2020-12-31 $10
2020-09-30 $1
2020-06-30 $2
2020-03-31 $0
2019-12-31 $1
2019-09-30 $2
2019-06-30 $3
2019-03-31 $3
2018-12-31 $0
2018-09-30 $1
2018-06-30 $1
2018-03-31 $0
2017-12-31 $0
2017-09-30 $0
2017-06-30 $0
2017-03-31 $0
2016-12-31 $0
2016-09-30 $0
2016-06-30 $0
2016-03-31 $0
2015-12-31 $0
2015-09-30
2015-06-30
2015-03-31
2011-12-31 $0
2011-09-30 $0
2011-06-30 $0
2011-03-31 $0
2010-12-31 $0
2010-09-30 $0
2010-06-30 $0
2010-03-31 $0
2009-12-31 $0
2009-09-30 $0
2009-06-30 $0
2009-03-31 $0
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.001B $0.007B
NAYA Biosciences is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases and fertility. NAYA Biosciences, formerly known as INVO BIOSCIENCE, is based in SARASOTA, Fla.
Stock Name Country Market Cap PE Ratio
MYT Netherlands Parent B.V (LUXE) DE $0.643B 0.00
CAPITA (CTAYD) GB $0.274B 0.00
SAG Holdings (INEO) SG $0.013B 0.00
Aerovate Therapeutics (JBIO) US $0.010B 0.00